Company intelligence / Profile preview

BioNova Pharmaceuticals

Shanghai, Shanghai, Chinabionovapharma.com ↗

Ownership: Private
Development stage: Phase 2

Overview

BioNova is a clinical-stage biopharmaceutical company with an internal R&D engine and global collaborations. Its lead program BN301 is a CD74-targeting ADC for hematologic malignancies in Phase 1 trials. The company has additional assets targeting menin and PRMT5 for hematologic cancers and solid tumors, respectively. It has demonstrated capital efficiency, rapid clinical execution, and successful business development including outlicensing deals.

Therapeutic areas: Oncology
Modalities: Small moleculesAntibody-drug conjugates (ADCs)
Industry: Biotech

Drug pipeline

4 assets

belumosudil

NDA

Indications: Chronic graft-versus-host disease

3 more assets in the full pipeline.

Partnerships

Sutro Biopharma – collaboration on STRO‑001 ADC for Greater China marketsKadmon – partnership on KD025 for graft-versus-host disease in ChinaPharmaResources – small molecule drug discovery collaboration targeting hematologic malignancies

Beyond the preview

Go deeper on BioNova Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioNova Pharmaceuticals.